Literature DB >> 17551396

Predictive factors of histologic response to primary chemotherapy in patients with Ewing sarcoma.

Stefano Ferrari1, Franco Bertoni, Emanuela Palmerini, Costantino Errani, Patrizia Bacchini, Elettra Pignotti, Mario Mercuri, Alessandra Longhi, Marilena Cesari, Piero Picci.   

Abstract

A correlation between chemotherapy-induced necrosis and prognosis has been reported in Ewing sarcoma. To identify factors influencing histologic response data from 122 patients with Ewing sarcoma surgically treated were reviewed. Primary chemotherapy was based on vincristine, doxorubicin, cyclophosphamide, ifosfamide, actinomycin-D, and etoposide. Patients with complete necrosis or only scattered foci of viable tumor cells were good responders (GRs), the remaining patients poor responders (PRs). Age, sex, site and size of the tumor, fever at diagnosis, and lactate dehydrogenase level were clinical variables investigated. Mean age was 13.3+/-6 in GR and 18.1+/-9 in PR (P<0.0005); GR rate was 71% in patients<or=14 years, 39% in patients aged 15 to 18 years, and 26% in patient>18 years (P=0.003). Female were more likely to achieve a GR (F 64% vs. M 42%, P<0.02). After multivariate analysis sex and age retained statistical significance. Age and sex influence the histologic response in patients with Ewing sarcoma.

Entities:  

Mesh:

Year:  2007        PMID: 17551396     DOI: 10.1097/MPH.0b013e3180640d08

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  8 in total

1.  Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma.

Authors:  Idriss M Bennani-Baiti; Aaron Cooper; Elizabeth R Lawlor; Maximilian Kauer; Jozef Ban; Dave N T Aryee; Heinrich Kovar
Journal:  Clin Cancer Res       Date:  2010-06-04       Impact factor: 12.531

2.  Pathobiologic markers of the ewing sarcoma family of tumors: state of the art and prediction of behaviour.

Authors:  Alfredo Pinto; Paul Dickman; David Parham
Journal:  Sarcoma       Date:  2010-10-14

3.  Pathology of Ewing's sarcoma/PNET: Current opinion and emerging concepts.

Authors:  Saral S Desai; Nirmala A Jambhekar
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

4.  Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.

Authors:  Jae Pil Hwang; Ilhan Lim; Chang-Bae Kong; Dae Geun Jeon; Byung Hyun Byun; Byung Il Kim; Chang Woon Choi; Sang Moo Lim
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

5.  SERUM VALUES OF ALKALINE PHOSPHATASE AND LACTATE DEHYDROGENASE IN EWING'S SARCOMA.

Authors:  André Mathias Baptista; Juan Pablo Zumárraga; Renan Pires Negrão Dos Santos; Guilherme de Oliveira Haubert; Olavo Pires de Camargo
Journal:  Acta Ortop Bras       Date:  2016 Jul-Aug       Impact factor: 0.513

6.  Surgical management of pelvic Ewing's sarcoma in children and adolescents.

Authors:  Hongbin Fan; Zheng Guo; Jun Fu; Xiangdong Li; Jing Li; Zhen Wang
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

7.  The Prognostic Role of the C-Reactive Protein and Serum Lactate Dehydrogenase in a Pediatric Series of Bone Ewing Sarcoma.

Authors:  Giada Del Baldo; Rachid Abbas; Maria Antonietta De Ioris; Valentina Di Ruscio; Iside Alessi; Evelina Miele; Angela Mastronuzzi; Giuseppe Maria Milano
Journal:  Cancers (Basel)       Date:  2022-06-22       Impact factor: 6.575

8.  Effects of different treatments and other factors on the prognosis of patients with ewing sarcoma.

Authors:  Kunchi Hua; Yongcheng Hu
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.